Edward J Gane Selected Research

setrobuvir

4/2016

Interferon-free regimens containing setrobuvir for patients with genotype 1 chronic hepatitis C: a randomized, multicenter study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Edward J Gane Research Topics

Disease

63	Infections 04/2024 - 03/2007
26	Fibrosis (Cirrhosis) 11/2022 - 02/2008
25	Chronic Hepatitis B 04/2024 - 08/2007
20	Chronic Hepatitis C 01/2019 - 10/2008
12	Hepatitis B 11/2023 - 03/2007
8	Hepatitis C 01/2022 - 10/2008
6	Liver Cirrhosis (Hepatic Cirrhosis) 01/2020 - 05/2007
6	Liver Diseases (Liver Disease) 06/2016 - 08/2010
5	Hepatocellular Carcinoma (Hepatoma) 04/2024 - 02/2008
4	Nausea 01/2023 - 05/2013
3	Disease Progression 01/2023 - 09/2008
3	Vomiting 01/2023 - 06/2014
3	Persistent Infection 01/2016 - 08/2012
3	Anemia 01/2015 - 07/2013
3	End Stage Liver Disease 04/2012 - 03/2007
2	Neoplasms (Cancer) 04/2024 - 05/2007
2	Coronary Artery Disease (Coronary Atherosclerosis) 10/2020 - 03/2014
2	Chronic Renal Insufficiency 10/2020 - 01/2014
2	Fatty Liver 01/2020 - 08/2010
2	Fatigue 01/2017 - 05/2013
2	Diarrhea 01/2017 - 06/2014
2	Headache (Headaches) 01/2017 - 05/2013
2	Hepatitis 06/2016 - 08/2007
2	Neutropenia 05/2013 - 09/2012
1	Opioid-Related Disorders (Opiate Addiction) 07/2023
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2023
1	Human Viral Hepatitis 01/2023
1	Hyperbilirubinemia 01/2023
1	Human Influenza (Influenza) 01/2023

Drug/Important Bio-Agent (IBA)

29	Antiviral Agents (Antivirals)IBA 04/2024 - 09/2008
21	Ribavirin (Virazole)FDA LinkGeneric 10/2020 - 02/2010
20	SofosbuvirIBA 10/2020 - 01/2013
12	InterferonsIBA 01/2021 - 10/2010
10	Hepatitis B e AntigensIBA 11/2023 - 01/2010
9	DNA (Deoxyribonucleic Acid)IBA 11/2023 - 01/2010
9	velpatasvirIBA 10/2019 - 12/2015
8	ledipasvirIBA 10/2020 - 03/2014
7	Lamivudine (Epivir)FDA Link 09/2014 - 03/2007
6	NucleotidesIBA 01/2023 - 08/2007
6	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2023 - 06/2010
5	grazoprevirIBA 07/2023 - 11/2016
5	NucleosidesIBA 01/2023 - 08/2007
5	Protease Inhibitors (Protease Inhibitor)IBA 01/2016 - 10/2010
4	RNA (Ribonucleic Acid)IBA 11/2023 - 02/2010
4	elbasvirIBA 07/2023 - 11/2016
4	Immunoglobulins (Immunoglobulin)IBA 10/2017 - 03/2007
4	sofosbuvir drug combination ledipasvirIBA 01/2017 - 01/2016
4	peginterferon alfa-2a (Pegasys)FDA Link 05/2013 - 02/2010
3	AntigensIBA 11/2023 - 01/2017
3	Opioid Analgesics (Opioids)IBA 07/2023 - 11/2016
3	selgantolimodIBA 01/2023 - 01/2020
3	Tenofovir (Viread)FDA Link 01/2018 - 09/2014
3	voxilaprevirIBA 01/2017 - 01/2016
3	danoprevirIBA 05/2016 - 10/2010
2	VaccinesIBA 04/2024 - 01/2016
2	ProdrugsIBA 01/2023 - 01/2018
2	Toll-Like Receptor 8IBA 10/2021 - 01/2020
2	CreatinineIBA 10/2020 - 01/2014
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2019
2	Alanine Transaminase (SGPT)IBA 01/2020 - 05/2014
2	sofosbuvir velpatasvir voxilaprevir drug combinationIBA 01/2019 - 01/2017
2	SimeprevirIBA 12/2018 - 01/2017
2	vesatolimodIBA 01/2018 - 08/2015
2	tenofovir alafenamideIBA 01/2018 - 03/2015
2	ruzasvirIBA 12/2017 - 11/2017
2	uprifosbuvirIBA 12/2017 - 11/2017
2	Ritonavir (Norvir)FDA Link 05/2016 - 11/2011
2	faldaprevirIBA 02/2015 - 01/2015
2	deleobuvirIBA 02/2015 - 01/2015
2	Emtricitabine (Emtriva)FDA Link 09/2014 - 05/2014
2	lipoarabinomannan (LAM)IBA 09/2014 - 03/2013
2	vaniprevirIBA 06/2014 - 07/2013
2	Telbivudine FDA Link 01/2014 - 05/2011
2	hepatitis B hyperimmune globulinIBA 03/2013 - 03/2007
2	Peptides (Polypeptides)IBA 11/2012 - 01/2010
2	Amino Acids FDA Link 11/2012 - 01/2010
2	Proteins (Proteins, Gene)FDA Link 08/2008 - 05/2007
1	Cancer VaccinesIBA 04/2024
1	Programmed Cell Death 1 ReceptorIBA 04/2024
1	Complementarity Determining Regions (Complementarity Determining Region)IBA 04/2024
1	pembrolizumabIBA 04/2024
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 04/2024
1	Immune Checkpoint InhibitorsIBA 04/2024
1	Toll-Like Receptor 7IBA 01/2023
1	RO7020531IBA 01/2023
1	Hepatitis B AntigensIBA 01/2023
1	EnzymesIBA 01/2023
1	CytokinesIBA 01/2023
1	Interferon Type IIBA 01/2023
1	entecavir FDA Link 11/2022
1	Reverse Transcriptase InhibitorsIBA 11/2022

Therapy/Procedure

33	Therapeutics 04/2024 - 08/2007
11	Liver Transplantation 01/2019 - 03/2007
6	Transplantation 10/2020 - 04/2012
3	Aftercare (After-Treatment) 04/2024 - 01/2018
3	Duration of Therapy 04/2024 - 01/2016
2	Drug Tapering 01/2023 - 09/2012
2	Retreatment 01/2019 - 10/2017
2	Immunotherapy 11/2012 - 01/2010
1	RNAi Therapeutics 11/2023